Henry I. Miller M.D.
Henry I. Miller M.D.
Home  |  Bio  |  Mobile Site  |  Follow @Twitter
Pundicity: Informed Opinion and Review
 

Latest Articles

Does the Government Have a Role in Combating Vaccine Misinformation?
Prominent physicians groups argue that misinformation about vaccines reduces immunization uptake, hindering their effectiveness as part of a well-functioning public health system

March 14, 2024  •  DC Journal (Inside Sources)

Vaccines are crucial in preventing diseases, saving lives, reducing disability and lightening the burden on the nation's healthcare system. Therefore, the government has a compelling interest in combating vaccine misinformation to prevent the promulgation of factually incorrect information that causes deaths.

That is the argument presented in an amicus brief filed with the Supreme Court in Murthy v. Missouri by several prominent medical organizations, including the American Medical Association, American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians and American Geriatrics Society.

Continue to the full article  |  More articles

 

Tales from the front lines in the 'vaccine wars': Review of Peter Hotez's Book, 'The Deadly Rise of Anti-Science'
An articulate plea for scientists to engage with the public, to defend themselves and their research against aggression, and to combat disinformation.

March 13, 2024  •  Genetic Literacy Project

If I don't write this or stand up for vaccines, then who will?

That is what motivates the activism of prominent academic vaccine researcher Peter Hotez, M.D., Ph.D., and drove him to write, "The Deadly Rise of Anti-Science," published by Johns Hopkins University Press.

A pediatrician and developer of vaccines for neglected infectious diseases in low- and middle-income countries, Dr. Hotez, in his iconic glasses, beard, bowtie, and wearing a perpetual smile, has become a media darling or devil — a steadfast defender and hero of science for mainstream news outlets, but a target of attack by the right.

Continue to the full article  |  More articles

 

A New Drug Offers Hope For A Common, Life-Threatening Liver Disease
Resmetirom may offer a lifeline for millions of patients, promoting a better quality of life and increased longevity

March 12, 2024  •  American Council on Science & Health

Addendum: The FDA granted Resmetirom accelerated approval on March 14, 2024.

Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD), a condition in which the liver builds up excessive fat deposits. A progressive disease with no current cure, it affects millions worldwide, including about 1.5-6.5% of U.S. adults. With its potential to evolve into cirrhosis and even liver cancer, the disease casts a long shadow over patients' lives and creates a significant burden on healthcare systems. However, a recent Phase 3 clinical trial published in the New England Journal of Medicine offers hope that a novel drug, resmetirom, will be the first FDA-approved treatment for NASH.

Continue to the full article  |  More articles

 

'Oppenheimer,' the Manhattan Project, and Me
The film is an important reminder of what happened and what DIDN'T happen in 1945

March 7, 2024  •  DC Journal (Inside Sources)

I just watched the highly praised film "Oppenheimer," which got me musing about history — my own and America's.

The movie is a biopic about J. Robert Oppenheimer, the brilliant theoretical physicist who directed the Los Alamos Laboratory, the nucleus of the Manhattan Project, the military research program that developed the atomic bombs dropped on Hiroshima and Nagasaki, ending World War II.

By mid-1945, the United States had been at war for three-and-a-half years, enduring the draft, separation from loved ones, rationing, and mounting numbers of casualties, with no end in sight. Americans were weary.

The film reminded me of the scientific and technological miracle at Los Alamos and also what did not happen.

Continue to the full article  |  More articles

 

Don't Underestimate The Economic Benefits Of The COVID Vaccines
They not only saved 2.9 million lives and prevented 12.5 million hospitalizations, but also saved $500 billion in hospitalization costs

March 5, 2024  •  American Council on Science & Health

From the onset of the COVID-19 pandemic, researchers have been engaged in forecasting the potential economic and human costs associated with an uncontrolled large-scale pandemic, as well as the corresponding benefits that could be derived from an effective COVID-19 vaccine and various degrees of its uptake. These projections have played a pivotal role in shaping both private and public responses to the pandemic.

Continue to the full article  |  More articles

home   |   biography   |   articles   |   mailing list   |   mobile site